Correlating telomerase activity levels with human neuroblastoma outcomes
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Telomerase activity was analysed in 100 neuroblastoma cases. Although telomerase activity was not detected in normal adrenal tissues or benign ganglioneuromas, almost all neuroblastomas (94%) did express it, suggesting an important role for telomerase in neuroblastoma development. Neuroblastomas with high telomerase activity had other genetic changes (for example, N-myc amplification) and an unfavourable prognosis, whereas tumours with low telomerase activity were devoid of such genetic alterations and were associated with a favourable prognosis. Three neuroblastomas lacking telomerase activity regressed (stage IVS). Thus telomerase expression may be required as a critical step in the multigenetic process of tumorigenesis, and two different pathways may exist for the development of neuroblastoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“whereas the late-stage disease has high telomerase activity and correlates with a poor outcome (6).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [6]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Brodeur, G. M., Pritchard, J., Berthold, F., Carlsen, N. L., Castel, V, Castelberry, R. P., De Bernardi, B., Evans, A. E., Favrot, M., & Hedborg, F. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1466 · Cited by 2,294
Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,262
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Association of Multiple Copies of the N-myc Oncogene with Rapid Progression of Neuroblastomas
Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., & Hammond, D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510313131802 · Cited by 2,010
Olovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
Cited by
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Self-citationThe RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Neuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
Matthay, K. K., Maris, J. M., Schleiermacher, G., Nakagawara, A., Mackall, C. L., Diller, L., & Weiss, W. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.78 · Cited by 1,419
Telomeres and telomerase: three decades of progress
Shay, J. W., & Wright, W. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0099-1 · Cited by 924
Self-citationNeuroblastoma: developmental biology, cancer genomics and immunotherapy
Cheung, N.-K. V., & Dyer, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3526 · Cited by 801
Regulation of Telomerase by Telomeric Proteins
Smogorzewska, A., & de Lange, T. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.071403.160049 · Cited by 798
Inhibition of Human Telomerase by a G-Quadruplex-Interactive Compound
Sun, D., Thompson, B., Cathers, B. E., Salazar, M., Kerwin, S. M., Trent, J. O., Jenkins, T. C., Neidle, S., & Hurley, L. H. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970199z · Cited by 794
Kim, N. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.13.2595 · Cited by 686
Role of Telomeres and Telomerase in Aging and Cancer
Shay, J. W. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0062 · Cited by 668
Self-citationWang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
“Of these, 11 showed amplification of the N-Myc locus (Hiyama et al. 1995).”
BackgroundMolecular Biology of Neuroblastoma
Maris, J. M., & Matthay, K. K. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2264 · Cited by 639
Shimada, H., Ambros, I. M., Dehner, L. P., Hata, J.-I., Joshi, V. V., & Roald, B. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2<349::aid-cncr20>3.0.co;2-y · Cited by 586
“showed that the telomerase enzyme was inactive in the regression of Stage 4-S neuroblastomas.(22) It is fair to state that the underlying mechanism(s) of spontaneous regression of neuroblastoma currently are not fully understood, but increasing evidence suggests that genetic prerequisites that allow the process of reg…”
BackgroundRusso, C. L., Pellarin, M., Tingby, O., Bollen, A. W., Lamborn, K. R., Mohapatra, G., Collins, V. P., & Feuerstein, B. G. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2<316::aid-cncr16>3.0.co;2-t · Cited by 153
Shimada, H., Ambros, I. M., Dehner, L. P., Hata, J., Joshi, V. V., & Roald, B. (1999) · PubMed · Cited by 573
Herbert, B.-S., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., & Corey, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14276 · Cited by 539
Self-citationShay, J. W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.677 · Cited by 509
Self-citationKyo, S. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.3.669 · Cited by 494
Telomeres, stem cells, senescence, and cancer
Sharpless, N. E., & DePinho, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20761 · Cited by 473
Yuan, X., Larsson, C., & Xu, D. (2019) · Oncogene · doi:10.1038/s41388-019-0872-9 · Cited by 450
Telomerase activity in gastric cancer.
Hiyama, E., Yokoyama, T., Tatsumoto, N., Hiyama, K., Imamura, Y., Murakami, Y., Kodama, T., Piatyszek, M. A., Shay, J. W., & Matsuura, Y. (1995) · PubMed · Cited by 463
Self-citationTelomerase Activity in Human Breast Tumors
Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., & Shay, J. W. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.2.116 · Cited by 423
“Among these tumors, telomerase activity was detected in 94% of neuroblastoma ( 27 ), 80% of lung cancer (28), 93% of colorectal cancer (29), 85% of hepatocellula r carcinoma (30), and 85% of gastric cancer (31).”
BackgroundSelf-citationGreenberg, R. A., O'Hagan, R. C., Deng, H., Xiao, Q., Hann, S. R., Adams, R. R., Lichtsteiner, S., Chin, L., Morin, G. B., & DePinho, R. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202669 · Cited by 411
“…contributed equally to this work Received 15 December 1998; revised 11 January 1999; accepted 12 January 1999 Oncogene (1999) 18, 1219 ± 1226 ã 1999 Stockton Press All rights reserved 0950 ± 9232/99 $12.00 http://www.stockton-press.co.uk/onc with high telomerase activity (Hiyama et al., 1995).”
BackgroundInfluentialPiatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E., & Shay, J. W. (1995) · Methods in Cell Science · doi:10.1007/bf00981880 · Cited by 384
“Telomerase is a ribonucleoprotein [27-29] that synthesizes telomeric DNA in normal germline tissues (such as testes and ovaries) and most immortal/tumor cells [9-11, 30, 31].”
BackgroundSelf-citationRegulation of Telomerase Activity in Immortal Cell Lines
Holt, S. E., Wright, W. E., & Shay, J. W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2932 · Cited by 361
Self-citationInhibition of human telomerase activity by peptide nucleic acids
Norton, J. C., Piatyszek, M. A., Wright, W. E., Shay, J. W., & Corey, D. R. (1996) · Nature Biotechnology · doi:10.1038/nbt0596-615 · Cited by 343
Self-citationA mechanistic classification of clinical phenotypes in neuroblastoma
Ackermann, S., Cartolano, M., Hero, B., Welte, A., Kahlert, Y., Roderwieser, A., Bartenhagen, C., Walter, E., Gecht, J., Kerschke, L., et al. (2018) · Science · doi:10.1126/science.aat6768 · Cited by 335
Strahl, C., & Blackburn, E. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.53 · Cited by 335
“However, in some tumor samples, the reported telomere lengths were much greater than those of normal surrounding tissues, while other tumor samples showed no changes compared with normal donor cells (19, 35, 39).”
BackgroundResultGowan, S. M., Harrison, J. R., Patterson, L., Valenti, M., Read, M. A., Neidle, S., & Kelland, L. R. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12212-2 · Cited by 303
Gene perturbation and intervention in probabilistic Boolean networks
Shmulevich, I., Dougherty, E. R., & Zhang, W. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.10.1319 · Cited by 296
“In the majority of tumor cells, telomerase is activated, which is believed to contribute to the prolonged life-span of the tumor cells (Kim et al., 1994) and worsened prognosis for the cancer patients (Hiyama et al., 1995; Zhang et al., 1996).”
BackgroundTelomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells
Engelhardt, M., Kumar, R., Albanell, J., Pettengell, R., Han, W., & Moore, M. A. S. (1997) · Blood · doi:10.1182/blood.v90.1.182 · Cited by 297
Mechanisms of neuroblastoma regression
Brodeur, G. M., & Bagatell, R. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.168 · Cited by 284
Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)
Poole, J. C., Andrews, L. G., & Tollefsbol, T. O. (2001) · Gene · doi:10.1016/s0378-1119(01)00440-1 · Cited by 274
Detection of Telomerase Activity in Malignant and Nonmalignant Skin Conditions
Stan Taylor, R., Ramirez, R. D., Ogoshi, M., Chaffins, M., Piatyszek, M. A., & Shay, J. W. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12345811 · Cited by 267
Self-citationStudies of the molecular mechanisms in the regulation of telomerase activity
LIU, J. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2091 · Cited by 254
Furumoto, K., Inoue, E., Nagao, N., Hiyama, E., & Miwa, N. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00351-8 · Cited by 240
Self-citationSpontaneous regression of neuroblastoma
Brodeur, G. M. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2761-2 · Cited by 235
“Hiyama et al. (1995) examined the telomere length and telomerase activity of 100 neuroblastoma samples.”
BackgroundBiology and Genetics of Human Neuroblastomas
Brodeur, G. M., Maris, J. M., Yamashiro, D. J., Hogarty, M. D., & White, P. S. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199703000-00001 · Cited by 236
Telomerase activity: A biomarker of cell proliferation, not malignant transformation
Belair, C. D., Yeager, T. R., Lopez, P. M., & Reznikoff, C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13677 · Cited by 236
Role of telomerase in cellular proliferation and cancer
Holt, S. E., & Shay, J. W. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199907)180:1<10::aid-jcp2>3.0.co;2-d · Cited by 259
Self-citationCell cycle-dependent modulation of telomerase activity in tumor cells.
Zhu, X., Kumar, R., Mandal, M., Sharma, N., Sharma, H. W., Dhingra, U., Sokoloski, J. A., Hsiao, R., & Narayanan, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6091 · Cited by 226
Telomerase activity in human brain tumours
Langford, L. A., Piatyszek, M. A., Shay, J. W., & Schold, S. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91865-5 · Cited by 218
Self-citationTelomerase Activity in Candidate Stem Cells From Fetal Liver and Adult Bone Marrow
Yui, J., Chiu, C.-P., & Lansdorp, P. M. (1998) · Blood · doi:10.1182/blood.v91.9.3255 · Cited by 216
Telomerase activity is detected in pancreatic cancer but not in benign tumors.
Hiyama, E., Kodama, T. S., Shinbara, K., Iwao, T., Itoh, M., Hiyama, K., Shay, J. W., Matsuura, Y., & Yokoyama, T. (1997) · PubMed · Cited by 224
Self-citationNaasani, I., Oh-hashi, F., Oh‐hara, T., Feng, W. Y., Johnston, J. S., Chan, K., & Tsuruo, T. (2003) · PubMed · Cited by 236
Clinical utility of telomerase in cancer
Hiyama, E., & Hiyama, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205070 · Cited by 202
“Initially, serial dilution of the tissue extract was used and then the signal intensity ratio to the positive control with internal standard was recommended (Hiyama et al., 1995a,d; Wright et al., 1995).”
BackgroundMethodInfluentialSelf-citationThe biologic basis for neuroblastoma heterogeneity and risk stratification
Maris, J. M. (2005) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000150631.60571.89 · Cited by 201
Harley, C. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205076 · Cited by 150
“…CA 94025, USA; E-mail: charley@geron.com apparently slowing the net rate of telomere loss and conferring an extended, but still ®nite lifespan to these cells (Bodnar et al., 1996; Hiyama et al., 1995b; Taylor et al., 1996; Usselmann et al., 2001; Weng et al., 1996, 1997) (Figure 2A, line b).”
BackgroundAlbanell, J., Engelhardt, M., Han, W., Moore, M. A. S., Lonardo, F., Rusch, V., Langenfeld, J., Klimstra, D., Venkatraman, E., & Dmitrovsky, E. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1609 · Cited by 193
Yoshida, K., Sugino, T., Tahara, H., Woodman, A., Bolodeoku, J., Nargund, V., Fellows, G., Goodison, S., Tahara, E., & Tarin, D. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970115)79:2<362::aid-cncr20>3.0.co;2-y · Cited by 193
Hiyama, E., & Hiyama, K. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00709-7 · Cited by 179
Self-citationEngelhardt, M. M., Drullinsky, P. R., Guillem, J. G., & Moore, M. A. S. (1997) · PubMed · Cited by 227
Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
Tahara, H., Kuniyasu, H., Yokozaki, H., Yasui, W., Shay, J. W., Ide, T., & Tahara, E. (1995) · PubMed · Cited by 186
Self-citationTelomere-related Genome Instability in Cancer
DE LANGE, T. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.032 · Cited by 182
“Neuroblastoma can also arise without telomerase activation and, in this tumor type, absence of telomerase is correlated with better outcome (Hiyama et al. 1995, 1997; Streutker et al. 2001).”
BackgroundClinical implications of telomerase in cancer
Kim, N. W. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00057-9 · Cited by 180
Contributions of Myc to tumorigenesis
Lutz, W., Leon, J., & Eilers, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00036-7 · Cited by 177
Kyo, S., & Inoue, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205163 · Cited by 174
“In contrast, telomerase activity in hematopoietic cells, is detected only in primitive stem cells, such as CD34+CD38+ cells or CD34+CD7 cells (Hiyama et al., 1995b).”
BackgroundInfluentialBehaviour of Telomere and Telomerase during Aging and Regeneration in Zebrafish
Anchelin, M., Murcia, L., Alcaraz-Pérez, F., García-Navarro, E. M., & Cayuela, M. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016955 · Cited by 168
Spontaneous regression of cancer
Papac, R. J. (1996) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(96)90023-7 · Cited by 168
Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
Lin, K., Zhao, Z.-Z., Bo, H.-B., Hao, X.-J., & Wang, J.-Q. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01323 · Cited by 167
Refining the telomere-telomerase hypothesis of aging and cancer
Holt, S. E., Shay, J. W., & Wright, W. E. (1996) · Nature Biotechnology · doi:10.1038/nbt0796-836 · Cited by 167
Self-citationHiyama, E., Hiyama, K., Yokoyama, T., & Shay, J. W. (2001) · Neoplasia · doi:10.1038/sj.neo.7900134 · Cited by 162
Self-citationTelomerase in the early detection of cancer.
Shay, J. W., & Gazdar, A. F. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.2.106 · Cited by 160
Self-citationTransformation of normal human cells in the absence of telomerase activation
Seger, Y. R., Garcı́a-Cao, M., Piccinin, S., Cunsolo, C. L., Doglioni, C., Blasco, M. A., Hannon, G. J., & Maestro, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00183-6 · Cited by 159
“They were derived tumor grade/stage (Chadeneau et al., 1995; Hiyama et al., 1995; from a 19-year-old Caucasian male and their lifespan has not been determined.”
BackgroundExperimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids.
Wright, W. E., Brasiskyte, D., Piatyszek, M. A., & Shay, J. W. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00519.x · Cited by 158
Self-citationBiological Role of Anaplastic Lymphoma Kinase in Neuroblastoma
Osajima-Hakomori, Y., Miyake, I., Ohira, M., Nakagawara, A., Nakagawa, A., & Sakai, R. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62966-5 · Cited by 170
Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas
Norrback, K., Dahlenborg, K., Carlsson, R., & Roos, G. (1996) · Blood · doi:10.1182/blood.v88.1.222.222 · Cited by 156
Ohira, M., Oba, S., Nakamura, Y., Isogai, E., Kaneko, S., Nakagawa, A., Hirata, T., Kubo, H., Goto, T., Yamada, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.019 · Cited by 155
“Other indicators also include telomerase (Hiyama et al., 1995), CD44 (Favrot et al., 1993), pleiotrophin (Nakagawara et al., 1995), N-cadherin (Shimono et al., 2000), CDC10 (Nagata et al., 2000), and Fyn (Berwanger et al., 2002).”
BackgroundNaasani, I., Seimiya, H., Yamori, T., & TSURUO, T. (1999) · PubMed · Cited by 155
In situ analysis of changes in telomere size during replicative aging and cell transformation.
Henderson, S. C., Allsopp, R., Spector, D. L., Wang, S. S., & Harley, C. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.134.1.1 · Cited by 162
“, 1994) and appears to be either absent or present at very low levels in most adult somatic tissues (Counter et al., 1992; Kim et al., 1994; Broccoli et al., 1995; Chiu et al., 1996; Counter et al., 1995; Hiyama et al., 1995).”
BackgroundIs telomerase a viable target in cancer?
Buseman, C. M., Wright, W. E., & Shay, J. W. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.07.006 · Cited by 148
“Indeed, tumors which have short telomeres and no detectable telomerase activity are selflimiting, and almost always regress spontaneously [53,54].”
Self-citationDevelopmental regulation of telomerase activity in human fetal tissues during gestation
Ulaner, G. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.9.769 · Cited by 148
Telomeres, telomerase, and myc. An update
Cerni, C. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(99)00091-5 · Cited by 160
Thyroid papillary carcinoma of columnar cell type
Wenig, B. M., Thompson, L. D. �., Adair, C. F., Shmookler, B. M., & Heffess, C. S. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980215)82:4 · Cited by 163
Inhibition of human telomerase by 2′- O -methyl-RNA
Pitts, A. E., & Corey, D. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11549 · Cited by 144
Telomerase in human development and cancer
Shay, J. W. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199711)173:2<266::aid-jcp33>3.0.co;2-b · Cited by 141
Self-citationDetection of Telomerase Activity in Exfoliated Cells in Urine From Patients With Bladder Cancer
Kinoshita, H., Ogawa, O., Kakehi, Y., Mishina, M., Itoh, N., Yamada, H., Terachi, T., & Yoshida, O. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.10.724 · Cited by 153
Telomerase Activity and Survival of Patients With Node-Positive Breast Cancer
Clark, G. M., Osborne, C. K., Levitt, D., Wu, F., & Kim, N. W. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.24.1874 · Cited by 152
Engelhardt, M. M., MacKenzie, K. L., Drullinsky, P. R., Silver, R. T., & Moore, M. A. S. (2000) · PubMed · Cited by 154
Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma
Berwanger, B., Hartmann, O., Bergmann, E., Bernard, S., Nielsen, D., Krause, M., Kartal, A., Flynn, D. C., Wiedemeyer, R., Schwab, M., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00179-4 · Cited by 136
Remarkable Differences in Telomere Lengths among Cloned Cattle Derived from Different Cell Types1
Miyashita, N., Shiga, K., YONAI, M., Kaneyama, K., Kobayashi, S., Kojima, T., Goto, Y., Kishi, M., Aso, H., Suzuki, T., et al. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.6.1649 · Cited by 137
“In humans, it was reported that telomerase activities are not detected in most somatic cells except for a part of the stem cells and fetal cells [32–34], and that telomerase activities even in telomerase-positive somatic cells are lost quickly by culture and particularly during passage [35].”
BackgroundE2F-1 represses transcription of the human telomerase reverse transcriptase gene
Crowe, D. L. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.13.2789 · Cited by 135
“Telomerase activation has been suggested to be a late event in tumorigenesis (26) and high levels of activity result in an unfavorable clinical prognosis (27).”
The reactivation of telomerase activity in cancer progression
Shay, J. W., & Wright, W. E. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)30018-8 · Cited by 142
Self-citationTelomerase activity in ordinary meningiomas predicts poor outcome
Langford, L. A., Piatyszek, M. A., Xu, R., Schold, S. C., Wright, W. E., & Shay, J. W. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90029-0 · Cited by 133
Self-citationTelomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Mao, L., El‐Naggar, A. K., Fan, Y. H., Lee, J., Lippman, S. M., Kayser, S., Lotan, R., & Hong, W. K. (1996) · PubMed · Cited by 142
Tatsumoto, N., Hiyama, E., Murakami, Y., Imamura, Y., Shay, J. W., Matsuura, Y., & Yokoyama, T. (2000) · PubMed · Cited by 149
Self-citationHolt, S. E., Norton, J. C., Wright, W. E., & Shay, J. W. (1996) · Methods in Cell Science · doi:10.1007/bf00132889 · Cited by 131
Self-citationLou, X., Zhuang, Y., Zuo, X., Jia, Y., Hong, Y., Min, X., Zhang, Z., Xu, X., Liu, N., Xia, F., et al. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b01099 · Cited by 134
Bechter, O. E., Eisterer, W., Pall, G., Hilbe, W., Kühr, T., & Thaler, J. (1998) · PubMed · Cited by 144
Wu, Y.-L., Dudognon, C., Nguyen, E., Hillion, J., Pendino, F., Tarkanyi, I., Aradi, J., Lanotte, M., Tong, J.-H., Chen, G.-Q., et al. (2006) · Journal of Cell Science · doi:10.1242/jcs.03001 · Cited by 126
Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga, S., Ohnishi, T., Izumoto, S., Miyahara, E., Kanemura, Y., Matsumura, H., & Arita, N. (1998) · PubMed · Cited by 133
Berthold, F., & Hero, B. (2000) · Drugs · doi:10.2165/00003495-200059060-00006 · Cited by 123
Telomeres and telomerase: biological and clinical importance
Dahse, R., Fiedler, W., & Ernst, G. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.5.708 · Cited by 121
“Neuroblastomas of a special stage (stage IV), which had short telomeres and no or weak telomerase activity, tended to regress spontaneously [49]—possible proof of a correlation between an enzyme activity too weak to remain in an immortal tumor status and a favorable outcome for the patient.”
Hoos, A., Hepp, H. H., Kaul, S., Ahlert, T., Bastert, G., & Wallwiener, D. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980220)79:1<8::aid-ijc2>3.0.co;2-5 · Cited by 72
Telomerase and the aging process
Hornsby, P. J. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.03.007 · Cited by 133
“There may a few cancers that do grow extensively and then stop because of lack of telomerase (Hiyama et al., 1995).”
BackgroundTelomerase Activity in Primary Prostate Cancer
Lin, Y., Uemura, H., Fujinami, K., Hosaka, M., Harada, M., & Kubota, Y. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65160-7 · Cited by 113
Sugino, T., Yoshida, K., Bolodeoku, J., Tahara, H., Buley, I., Manek, S., Wells, C., Goodison, S., Ide, T., Suzuki, T., et al. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960822)69:4<301::aid-ijc11>3.0.co;2-8 · Cited by 115
Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres
Dagg, R. A., Pickett, H. A., Neumann, A. A., Napier, C. E., Henson, J. D., Teber, E. T., Arthur, J. W., Reynolds, C. P., Murray, J., Haber, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.087 · Cited by 110
Aging and cancer: are telomeres and telomerase the connection?
Shay, J. W. (1995) · Molecular Medicine Today · doi:10.1016/s1357-4310(95)93872-9 · Cited by 116
Self-citationRole of Telomerase in Cell Senescence and Oncogenesis
Urquidi, V., Tarin, D., & Goodison, S. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.65 · Cited by 123
Metadata
- Authors
- Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Hiroshima University (JP)
- Venue
- Nature Medicine
- Published
- 1995-03
- Volume
- 1
- Issue
- 3
- Pages
- 249-255
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2050275508
- Cited by
- 611
- References
- 57
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 8 · 2020: 9 · 2019: 9 · 2018: 7 · 2017: 6 · 2016: 9 · 2015: 6 · 2014: 6 · 2013: 12 · 2012: 15
- FWCI
- 53.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG07992, R01AG007992)
- Topics
- Health Sciences › Medicine › Oncology › Neuroblastoma Research and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Keywords
- telomerase activity, neuroblastoma, prognosis, MYCN amplification, ganglioneuroma, carcinogenesis, tumor regression, tumor suppressor pathways
- MeSH terms
- Adrenal Gland Neoplasms, Adrenal Glands, Base Sequence, Child, Ganglioneuroma, Humans, Infant, Male, Molecular Sequence Data, Neuroblastoma, Prognosis, Telomere, DNA Primers, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.